Abstract
Elevated insomnia symptoms at baseline correlated with an increased risk of symptoms of anxiety, depression, and stress after 1 year, with significant sex differences observed. Logistic regression revealed that this association was significant only in females, although a consistent nonlinear pattern was seen in both sexes. Furthermore, CRY2 gene DNA methylation acted as a negative moderator of this relationship. These results highlight the necessity of an early monitoring strategy for females incorporating epigenetic factors.
Introduction
While the link between insomnia and mental health is well-established, the underlying biological mechanisms—and why these associations often appear stronger in women—remain poorly understood. Most research focuses on clinical populations, leaving a gap in our understanding of how these factors interact in the general population of young adults during the high-stress "college years." This study investigates whether the CRY2 gene, a core component of the internal circadian clock, plays a role in this relationship through DNA methylation—a chemical mechanism that regulates gene expression.
Methods and Data
The researchers conducted a one-year longitudinal study involving 1,100 Chinese college students (38.4% male, 61.6% female) recruited from universities in Hefei and Shangrao.
Insomnia was assessed using the Insomnia Severity Index (ISI) at baseline, while mental health outcomes (anxiety, depression, and stress) were measured using the Depression Anxiety Stress Scale (DASS-21) at a one-year follow-up. For a subset of 605 participants, targeted region methylation sequencing (MethylTarget™) was performed on the CRY2 gene using baseline blood samples. Statistical analysis included binary logistic regression, Restricted Cubic Spline (RCS) models to detect nonlinear relationships, and the Johnson–Neyman technique to identify moderation thresholds.
Key Insights and Results
The "J-Shaped" Risk Curve
The relationship between insomnia and mental health was found to be nonlinear. RCS analysis revealed a threshold effect: when insomnia scores were below 1.75 on the ISI, the risk for mental health issues remained stable. Beyond this inflection point, the risk for anxiety, depression, and stress rose sharply.
Sex-Specific Vulnerability
The longitudinal association was strikingly sex-specific. At the one-year follow-up, females with baseline insomnia symptoms were 3.96 times more likely to report anxiety, 3.04 times more likely to report depression, and 5.73 times more likely to report stress compared to those without insomnia. In contrast, linear associations in males did not reach statistical significance, though the nonlinear trend suggested that extreme insomnia still poses a risk.
The Epigenetic Shield
A critical discovery was that CRY2 methylation acts as a negative moderator. In females, higher levels of CRY2 methylation effectively "dampened" the negative impact of insomnia. Specifically, for every 0.01-unit increase in CRY2 DNA methylation, the impact of insomnia on anxiety symptoms was reduced by 59%, on depression by 57.3%, and on stress by 71%. This suggests that the epigenetic state of circadian genes may provide biological resilience against sleep-related psychological decline.
Discussion and Limitations
These findings highlight the importance of early monitoring for insomnia, particularly in young women, and suggest that epigenetic factors like CRY2 methylation could serve as biomarkers for mental health resilience.
However, the study has limitations:
- Self-Reporting: The use of scales for insomnia and mental health may introduce recall bias compared to clinical interviews.
- Single-Point Sampling: DNA methylation was only measured at baseline; future research should track epigenetic changes over time to observe fluctuations alongside sleep patterns.
- Causality: As an observational study, it cannot definitively prove that CRY2 methylation causes the reduction in risk, only that they are strongly associated.
Future research should explore other circadian clock genes (like PER or CLOCK) and investigate whether sleep-improvement interventions can shift these epigenetic markers to favor mental health resilience.
Summary updated